IntegriChain
Latest round
- Series B
Last raised
- May 2009
Total raised
- $6M
Investors
- 4
About IntegriChain
Founded in 2006 in Philadelphia, US, IntegriChain, Inc. provides crucial services in pharmaceutical commercialization.119 mn.IntegriChain specializes in providing comprehensive pharmaceutical commercialization and market access services through its core product, the ICyte platform. This unique data, analytics, and business process platform addresses the complexities associated with drug commercialization by unifying critical business functions such as contracts and pricing, gross-to-net calculations, channel management, and patient services. The end users of IntegriChain's offerings include pharmaceutical manufacturers ranging from startups to large enterprises, who rely on the platform to enhance their operational efficiency and maximize net revenue. IntegriChain’s solutions are designed to serve markets across North America and Europe, addressing the specific challenges of therapy commercialization and access in these regions.IntegriChain generates revenue primarily through a business-to-business model, offering subscription-based access to its ICyte platform along with consulting and managed services. Clients typically engage with the company through annual contracts that provide access to a suite of tools designed to optimize drug pricing and market access strategies. The revenue structure is built on ongoing partnerships with pharmaceutical companies that require consistent access to real-time data and analytics for decision-making. IntegriChain's offerings, which include consulting on pricing strategy and reimbursement processes, are integral to the operational success of their clients, ensuring they meet commercial obligations and enhance product utilization.In November 2023, Nordic Capital agreed to acquire a majority stake in IntegriChain, Inc. from Accel-KKR, with financial terms not disclosed. This acquisition is expected to accelerate IntegriChain's growth targets, supporting plans for further expansion into new markets and enhanced product offerings.
Who invested in IntegriChain
4 investors across 3 rounds
See all investors in IntegriChain
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about IntegriChain
Who invested in IntegriChain?
IntegriChain has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has IntegriChain raised?
IntegriChain has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did IntegriChain last raise money?
IntegriChain's most recent round on record is a Series B, in May 2009.
What does IntegriChain do?
Founded in 2006 in Philadelphia, US, IntegriChain, Inc.
Where is IntegriChain headquartered?
IntegriChain is headquartered in Philadelphia, US.
Which VCs invest in companies like IntegriChain?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at IntegriChain's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like IntegriChain? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.